A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/15329900

Cancer 2004 Sep 1 101 5 934-9

Download in:

View as

Triples

General Info

PMID
15329900